GSPT1 / Eukaryotic peptide chain release factor GTP-binding subunit ERF3A · Western blot design guide

Design a Western Blot for GSPT1

Source-linked GSPT1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GSPT1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for GSPT1: expected band ~55.8 kDa, hero antibody A07761, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable GSPT1 Western blot protocol sheet — expected band ~55.8 kDa, antibody A07761, controls and PMC citations. Open the full GSPT1 WB guide →

GSPT1 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~55.8 kDa
Gel 12–15% (standard starting point)
Positive control ⓘ Appendix (IHC candidate; verify WB) +4 more
Negative control ⓘ Adipose tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM —
Caveat —
Gene-set association MSigDB Hallmark membership
Isoform 3 isoform(s)
Section 1

Source-Linked GSPT1 Western Blot Protocol Options

The A07761 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysate3T3 cells (catalog A07761)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA07761; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected GSPT1 Western Blot Band Size?

GSPT1 has a predicted mass of 55.8 kDa; three annotated isoforms could affect migration, but no distinct band pattern is demonstrated.

What am I looking at on my blot?
Band near 55.8 kDaConsistent with the predicted GSPT1 mass; confirm identity with controls
Several discrete bandsCould reflect isoforms 1, 2, and 3; their migration is not established
Band above 55.8 kDaAn isoform is possible, but the band identity needs confirmation
Band below 55.8 kDaAn isoform is possible, but the band identity needs confirmation
💡Expected GSPT1 appearanceUniProt predicts 55.8 kDa for GSPT1; no empirical band size or isoform migration is supplied, so confirm any candidate band with ordinary identity controls.
How each factor affects band size
UniProt predicted massSets a 55.8 kDa reference for GSPT1
Splice isoform 1Its individual apparent mass is not supplied
Splice isoform 2Its apparent size may differ; no individual mass is supplied
Splice isoform 3Its apparent size may differ; no individual mass is supplied
Why is my band missing or off?
SituationLikely causeNext action
Multiple bandsIsoforms 1, 2, and 3 are annotated, but distinct bands are unprovenCheck isoform coverage and confirm bands with GSPT1 depletion
Band higher than expectedIts identity and migration cause are unestablishedCompare with GSPT1 depletion and an independent antibody
Band lower than expectedAn alternative isoform is possible; its size is unknownCheck antibody epitope coverage and confirm with GSPT1 depletion
No band in lysateGSPT1 may be below detection or the blot may have failedCheck loading and transfer, then use a positive control lysate
Weak or no signalTarget abundance or antibody recognition may be insufficientIncrease lysate input and verify the antibody with a positive control

Sample controls for GSPT1 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for GSPT1 in Western blot, you can use appendix tissue, which has high HPA expression.
Positive control: Appendix (IHC candidate; verify WB)
Negative control: Adipose tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: Adipose tissue is a feasible negative control because HPA reports GSPT1 as not detected there.

HPA tissue expression evidence for GSPT1

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Appendix glandular cells High Protein (IHC) HPA →
Bone marrow hematopoietic cells High Protein (IHC) HPA →
Breast glandular cells High Protein (IHC) HPA →
Bronchus respiratory epithelial cells High Protein (IHC) HPA →
Colon glandular cells High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Adipose tissue adipocytes Not detected Protein (IHC) HPA →
Caudate neuronal cells Low Protein (IHC) HPA →
Hippocampus neuronal cells Low Protein (IHC) HPA →
Parathyroid gland glandular cells Low Protein (IHC) HPA →
Placenta trophoblastic cells Low Protein (IHC) HPA →
Section 3

Advanced GSPT1 Western Blot Tips

Deeper troubleshooting and optimisation questions for GSPT1, answered from its protein features.

Where should the main GSPT1 band appear?
Band shift · The canonical sequence is 499 residues with a predicted mass of 55.8 kDa. Use this as a reference, not a guaranteed migration position; no observed band size is supplied.
Can GSPT1 isoforms produce different bands?
Isoforms · UniProt lists isoforms 1, 2, and 3 with alternative N-terminal sequences. They could migrate differently, but these features alone do not establish that separate bands will be visible.

In UniProt coordinates, the alternative sequence annotated at position 1 replaces the initial methionine in isoforms 2 and 3; an additional sequence is annotated as missing at position 8 in isoform 2. Check which sequence your antibody recognizes before assigning a band to an isoform.

Decide whether the measurement should include all three listed isoforms or distinguish them. Check the antibody’s recognized sequence against the annotated N-terminal differences, and quantify bands consistently with that choice.
Do annotated modifications prove a band shift?
PTM · The linked UniProt record describes protein features. A modification annotation alone does not demonstrate a visible shift; retain any condition or experimental qualifier attached to it.
Does this guide establish induction of GSPT1?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for GSPT1?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A07761 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should GSPT1 be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Does the predicted mass explain a shifted GSPT1 band?
Interpretation · The predicted mass is 55.8 kDa, and alternative sequences are annotated, but no empirical band position is supplied. Compare each observed band with the relevant isoform sequence; the listed features alone cannot explain a specific mass difference.

GSPT1 is listed as part of an eRF1–eRF3–GTP ternary complex and a transient SURF complex. Those annotations do not establish that a complex survives Western blot preparation or produces an extra band. Check band identity before assigning it to a complex.
Boster reagents

GSPT1 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western Blot analysis of 3T3 cells using eRF3a Polyclonal Antibody
Anti-eRF3a GSPT1 Antibody
Cat # A07761
Real WB data Western blot (WB) analysis of eRF3a (D128) pAb at 1:500 dilution Lane1:SGC7901 whole cell lysate(40ug) Lane2:Panc1 whole cell lysate(40ug) Lane3:PC3 whole cell lysate(40ug) Lane4:AML-12 whole cell lysate(40ug) Lane5:PC12 whole cell lysate(40ug)
Anti-eRF3a (D128) GSPT1 Antibody
Cat # A07761-1

Both anti-GSPT1 antibodies list Human, Mouse, and Rat reactivity and have WB images. A07761 shows 3T3 cells; A07761-1 shows SGC7901, Panc1, PC3, AML-12, and PC12 lysates at 1:500. These examples do not establish validation across all listed species.

Which to pick: Choose based on the reported sample: A07761 has a 3T3 WB example, while A07761-1 has examples from five cell lysates at 1:500. Both list the same species reactivity; neither has a unique reactivity advantage in the supplied evidence.

Source: BosterBio GSPT1 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.